Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction
Crossref DOI link: https://doi.org/10.1007/s12325-017-0618-4
Published Online: 2017-10-10
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Albert, Nancy M.
Drzayich Antol, Dana A.
DeClue, Richard W.
Casebeer, Adrianne Waldman
Li, Yong
Stemkowski, Stephen
Chang, Chun-Lan
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
License valid from 2017-10-01